Fig. 1. Consequences of diabetes-induced alterations in substrate metabolism and sources of increased ROS in DC. Increased FA uptake results in accumulation.

Slides:



Advertisements
Similar presentations
OVERVIEW OF METABOLISM Medical Biochemistry, Lecture 30.
Advertisements

Nucleic acids Carbohydrates Lipids Proteins Nucleic acids.
METABOLISM. The enzymatic reactions does not occur in isolation but rather they occurred in an organized manner i.e. a Pathway!!!
METABOLISM The chemical changes that occur in living organisms The chemical changes that occur in living organisms The Principal Organs: Digestive Organs.
Glycolysis Animation hill.com/sites/ /student_view0/chapter25/animation__ho w_glycolysis_works.html.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Adrenergic-Fatty Acid Load in Heart Failure J.
Date of download: 7/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: Metabolic Impairment in Heart Failure: The Myocardial.
March 27-28, 2017 Biology, Dynamics of Life Chapter 9, pages
KEY AREA 7: Cellular Respiration
22.2 Important Coenzymes in Metabolic Pathways
Pharmacological prevention of diabetic cataract
Metabolism in Nervous Tissue
Chapter 23 Fatty Acid Catabolism.
Packet #13 Short Edition Chapter #9
Oxidative Decarboxylation and Krebs Cycle
September 12 Chapter 24 G&G Fatty acid catabolism
Chapter 7: Metabolism The Basics Glycolysis TCA Fat Metabolism
Glycolysis.
FATTY ACID BIOSYNTHESIS
Normal And Abnormal Cardiac Muscle Metabolism
Respiration.
Nat. Rev. Rheumatol. doi: /nrrheum
Metabolism of cardiac muscle
Volume 54, Issue 4, Pages (April 2011)
Figure 3 Metabolism in homeostatic chondrocytes
Bart Staels, PhD  The American Journal of Medicine 
Figure 1 Pathophysiological aspects of insulin
SURVEY OF BIOCHEMISTRY Fatty Acid Oxidation
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
CELLULAR RESPIRATION.
Figure 1 Immune cell metabolism during homeostasis
Nat. Rev. Nephrol. doi: /nrneph
Figure 3 Metabolic configurations of M1 and M2 macrophages
Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1  Krishna K. Singh, PhD, Praphulla C. Shukla, PhD,
Volume 56, Issue 4, Pages (April 2012)
Figure 2 Metabolic reprogramming of immune cells upon activation
Figure 1 Metabolic adaptations of cancer cells
Nat. Rev. Nephrol. doi: /nrneph
Volume 54, Issue 4, Pages (April 2011)
Lactic Acidosis: Current Treatments and Future Directions
Figure 4 Altered metabolism in chondrocytes in osteoarthritis
NASH: a mitochondrial disease
Cut along the dotted lines then fold
Respiration BINGO.
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Patrick S. Ward, Craig B. Thompson  Cancer Cell 
Pyruvate Dehydrogenase
Metformin: From Mechanisms of Action to Therapies
ACSF3 and Mal(onate)-Adapted Mitochondria
Ng Shyh-Chang, George Q. Daley  Cell Metabolism 
Tumor Cell Metabolism: Cancer's Achilles' Heel
Volume 76, Issue 11, Pages (December 2009)
Conserved Metabolic Regulatory Functions of Sirtuins
Gabriela Andrejeva, Jeffrey C. Rathmell  Cell Metabolism 
Metabolic Plasticity in Stem Cell Homeostasis and Differentiation
Glycolytic and mitochondrial ATP production, the electron transport chain, and oxidative phosphorylation Glycolytic and mitochondrial ATP production, the.
Volume 11, Issue 5, Pages (November 2012)
Wayel Jassem, Nigel D. Heaton  Kidney International 
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 3, Issue 1, Pages 9-13 (January 2006)
Aerobic respiration. Aerobic respiration. There are 4 major reaction pathways including glycolysis, the conversion of pyruvate to acetyl-CoA, the TCA cycle,
Lipid Metabolism Greases the Stem Cell Engine
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Metformin: From Mechanisms of Action to Therapies
Main metabolic pathways deregulated in cancers and corresponding targeting drugs. Main metabolic pathways deregulated in cancers and corresponding targeting.
Harvesting Chemical Energy
Fig. 2. Potential mechanisms and effects of impaired Ca2+ handling in DC. Impairment in cardiomyocyte Ca2+ influx and efflux, impaired release and reuptake.
Overview of the dysfunctional metabolic pathways in pulmonary vascular cell types implicated in the development of pulmonary hypertension. Overview of.
Presentation transcript:

Fig. 1. Consequences of diabetes-induced alterations in substrate metabolism and sources of increased ROS in DC. Increased FA uptake results in accumulation of TAG, lipid intermediates and increased FA oxidation, all of which may harm the cardiomyocyte. Increased glucose entry into the cardiomyocyte may promote alternative pathways of glucose utilization, thus provoking an increase in ROS, AGE, and O-GlcNAcylation. Increased amounts of intramitochondrial ROS may be generated by the electron transport chain, by increased MAO activity or by increased calpain-1 levels, whereas NOX2, NOX4, and XO may contribute to increased cytosolic ROS generation.ROS, reactive oxygen species; DC, diabetic cardiomyopathy; FA, fatty acid; TAG, triacylglycerols; AGE, advanced glycation end product; NOX, NADPH oxidases; XO, xanthine oxidase; GLUT, glucose transport protein; CD, cluster of differentiation; FATP, fatty acid transport protein; ACS, acetyl-CoA synthetase; PPARα, peroxisome proliferator-activated receptor α; FAO, fatty acid oxidation; PPP, pentose phosphate pathway; NADPH, nicotinamide adenine dinucleotide phosphate; HBP, hexosamine biosynthetic pathway; O-GlcNAc, O-linked β-N-acetylglucosamine; SERCA, sarco(endo) plasmic reticulum Ca2+-ATPase; DAG, diacylglycerols; TAG, triacylglycerols; CPT, carnitine palmitoyltransferase; TCA, trichloroacetic acid; MAO, monoamine oxidases; PDH, pyruvate dehydrogenase; ADP, adenosine diphosphate; ATP, adenosine triphosphate; UCP, uncoupling protein. Fig. 1. Consequences of diabetes-induced alterations in substrate metabolism and sources of increased ROS in DC. Increased FA uptake results in accumulation of TAG, lipid intermediates and increased FA oxidation, all of which may harm the cardiomyocyte. Increased glucose entry into the cardiomyocyte may promote alternative pathways of glucose utilization, thus provoking an increase in ROS, AGE, and O-GlcNAcylation… J Lipid Atheroscler. 2019 May;8(1):26-47. https://doi.org/10.12997/jla.2019.8.1.26